We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
John Bean Technologies Up 41% YTD: Will the Rally Continue?
Read MoreHide Full Article
John Bean Technologies Corporation (JBT - Free Report) shares have surged 41.4% year to date, outperforming the industry's growth of 16.8%. Meanwhile, the Zacks S&P 500 composite has rallied 17.3% in the same timeframe. An encouraging outlook for 2019 and focus on acquisitions, developing innovative products and expanding recurring revenue base is likely to drive the stock.
John Bean Technologies has a market capitalization of $3.2 billion. Average volume of shares traded in the last three months was 188.9K.
Let’s delve deeper and analyze the reasons behind the Zacks Rank #3 (Hold) stock’s impressive price performance and find out if there is room for further appreciation:
Upbeat Q2: The company’s second-quarter 2019 adjusted earnings per share improved 12% year over year to $1.42. Revenues of $493 million also improved 0.4% year over year. The company beat the Zacks Consensus Estimate on both the metrics.
Upbeat Guidance: For 2019, John Bean Technologies’ earnings per share guidance stands at $4.70-$4.90. Compared with earnings per share of $4.28 in 2018, the mid-point of the guidance range reflects growth of 12%. The company continues to expect organic growth of 4-5%. Acquisitions are now anticipated to contribute around 7% to growth.
Positive Earnings Surprise History: John Bean Technologies outpaced the Zacks Consensus Estimate in three of the trailing four quarters, with an average positive earnings surprise of 28.79%.
Positive Earnings Growth Projections: The Zacks Consensus Estimate for the company’s earnings for the ongoing year is currently pegged at $4.83, suggesting growth of 12.85% from the year-ago quarter. The same for 2020 stands at $5.35, indicating a year-over-year improvement of 10.73%.The stock also has long-term expected earnings per share growth rate of 7.3%, higher than the industry’s growth rate of 5.5%.
Estimates Northbound: Earnings estimate revisions impact the stock prices significantly. The Zacks Consensus Estimate for John Bean Technologies’ current-year and the next-year earnings has moved up around 6% and 5%, respectively, over the past 90 days, reflecting analysts’ confidence in the stock.
Solid ROE: The company’s trailing 12-month ROE of 33.7% reinforces growth potential. The company's ROE is much higher than the industry’s 25.7%, highlighting the company's tactical efficiency in utilizing shareholders' funds.
Growth Drivers in Place: John Bean Technologies’ Elevate plan is likely to drive persistent growth and margin expansion. Per the plan, the company is focusing on accelerating development of innovative products and services to provide customers with solutions, which will enhance their yield and productivity.
The company is capitalizing on extensive installed base to expand recurring revenue (which accounts for around 40% of its revenues) from aftermarket parts and services, equipment leases, consumables and airport services. This portion of the business has been seeing a CAGR of 9% over the past three years. In fact, it has further room for growth and will contribute to the company’s margins.
John Bean Technologies has a strategic acquisition program focused on companies that add complementary products. Further, its ongoing restructuring plan will help improve effectiveness and productivity in all business units. Favorable industry trends in both segments and increased automation adoption among customers also bode well.
The company is poised to perform well in the long run, courtesy of growing middle class, increasing protein and value-added food and beverage consumption globally.
Atkore International Group has a projected earnings growth rate of 19.8% for the current year. The stock has gained 58% so far this year.
Cintas has an estimated earnings growth rate of 12.74% for 2019. Shares of the company have rallied 59% year to date.
Sharps Compliance has an estimated earnings growth rate of 500% for 2019. The company has rallied 25% so far this year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
John Bean Technologies Up 41% YTD: Will the Rally Continue?
John Bean Technologies Corporation (JBT - Free Report) shares have surged 41.4% year to date, outperforming the industry's growth of 16.8%. Meanwhile, the Zacks S&P 500 composite has rallied 17.3% in the same timeframe. An encouraging outlook for 2019 and focus on acquisitions, developing innovative products and expanding recurring revenue base is likely to drive the stock.
John Bean Technologies has a market capitalization of $3.2 billion. Average volume of shares traded in the last three months was 188.9K.
Let’s delve deeper and analyze the reasons behind the Zacks Rank #3 (Hold) stock’s impressive price performance and find out if there is room for further appreciation:
Upbeat Q2: The company’s second-quarter 2019 adjusted earnings per share improved 12% year over year to $1.42. Revenues of $493 million also improved 0.4% year over year. The company beat the Zacks Consensus Estimate on both the metrics.
Upbeat Guidance: For 2019, John Bean Technologies’ earnings per share guidance stands at $4.70-$4.90. Compared with earnings per share of $4.28 in 2018, the mid-point of the guidance range reflects growth of 12%. The company continues to expect organic growth of 4-5%. Acquisitions are now anticipated to contribute around 7% to growth.
Positive Earnings Surprise History: John Bean Technologies outpaced the Zacks Consensus Estimate in three of the trailing four quarters, with an average positive earnings surprise of 28.79%.
Positive Earnings Growth Projections: The Zacks Consensus Estimate for the company’s earnings for the ongoing year is currently pegged at $4.83, suggesting growth of 12.85% from the year-ago quarter. The same for 2020 stands at $5.35, indicating a year-over-year improvement of 10.73%.The stock also has long-term expected earnings per share growth rate of 7.3%, higher than the industry’s growth rate of 5.5%.
Estimates Northbound: Earnings estimate revisions impact the stock prices significantly. The Zacks Consensus Estimate for John Bean Technologies’ current-year and the next-year earnings has moved up around 6% and 5%, respectively, over the past 90 days, reflecting analysts’ confidence in the stock.
Solid ROE: The company’s trailing 12-month ROE of 33.7% reinforces growth potential. The company's ROE is much higher than the industry’s 25.7%, highlighting the company's tactical efficiency in utilizing shareholders' funds.
Growth Drivers in Place: John Bean Technologies’ Elevate plan is likely to drive persistent growth and margin expansion. Per the plan, the company is focusing on accelerating development of innovative products and services to provide customers with solutions, which will enhance their yield and productivity.
The company is capitalizing on extensive installed base to expand recurring revenue (which accounts for around 40% of its revenues) from aftermarket parts and services, equipment leases, consumables and airport services. This portion of the business has been seeing a CAGR of 9% over the past three years. In fact, it has further room for growth and will contribute to the company’s margins.
John Bean Technologies has a strategic acquisition program focused on companies that add complementary products. Further, its ongoing restructuring plan will help improve effectiveness and productivity in all business units. Favorable industry trends in both segments and increased automation adoption among customers also bode well.
The company is poised to perform well in the long run, courtesy of growing middle class, increasing protein and value-added food and beverage consumption globally.
Stocks to Consider
Some better-ranked stocks in the Industrial Products sector are Atkore International Group Inc. (ATKR - Free Report) , Cintas Corporation (CTAS - Free Report) and Sharps Compliance Corp , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Atkore International Group has a projected earnings growth rate of 19.8% for the current year. The stock has gained 58% so far this year.
Cintas has an estimated earnings growth rate of 12.74% for 2019. Shares of the company have rallied 59% year to date.
Sharps Compliance has an estimated earnings growth rate of 500% for 2019. The company has rallied 25% so far this year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>